维普中文期刊产品整合服务
22篇 您的检索式:作者名="Dominique Larrey"
    题名 作者 年代 出处 被引量
1Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr 2013Journal of Hepatology2013,,:2
2SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders显示文摘Christoph Sarrazin Regine Rouzier Frank Wagner Nicole Forestier Dominique Larrey Samir K. Gupta Musaddeq Hussain Amrik Shah David Cutler Jenny Zhang Stefan Zeuzem 2007Gastroenterology2007,,4:2
3Epidemiology and Individual Susceptibility to Adverse Drug Reactions Affecting the Liver显示文摘Dominique Larrey 2002Semin Liver Dis2002,,02:2
4Hepatitis C virus infection:are there still specific problems with genotype 3?显示文摘Hepatitis C virus(HCV) infection is one of the most common causes of chronic liver disease and the main indication for liver transplantation worldwide. As promising specific treatments have been introduced for genotype 1, clinicians and researchers are now focusing on patients infected by non-genotype 1 HCV, particularly genotype 3. Indeed, in the golden era of direct-acting antiviral drugs, genotype 3 infections are no longer considered as easy to treat and are associated with higher risk of developing severe liver injuries, such as cirrhosis and hepatocellular carcinoma. Moreover, HCV genotype 3 accounts for 40% of all HCV infections in Asia and is the most frequent genotype among HCV-positive injecting drug users in several countries. Here, we review recent data on HCV genotype 3 infection/treatment, including clinical aspects and the underlying genotype-specific molecular mechanisms.Claire Gondeau Georges Philippe Pageaux Dominique Larrey 2015World Journal of Gastroenterology2015,21,42:1
5Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890<!-- Doctopic: VH -->显示文摘Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr 2013Journal of Hepatology2013,,:1
6Are drugs a risk factor of post-ERCP pancreatitis?显示文摘Pascal Perney Emile Berthier Georges-Philippe Pageaux Dominique Hillaire-Buys Valérie Roques Pascale Fabbro-Peray Marianne Melki Bertrand Hanslik Paul Bauret Dominique Larrey Jean-Pierre Blayac Fran?ois Blanc 2003Gastrointestinal Endoscopy2003,,5:1
7Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication显示文摘Stéphanie Faure Astrid Herrero Boris Jung Yohan Duny Jean-Pierre Daures Thibaut Mura Eric Assenat Micha?l Bismuth Hassan Bouyabrine Hélène Donnadieu-Rigole Francis Navarro Samir Jaber Dominique Larrey Georges-Philippe Pageaux 2012Journal of Hepatology2012,,2:1
8Risk factors for lymphoproliferative disorders after liver transplantation in adults: an analysis of 480 patients显示文摘Christophe Duvoux Georges-Philippe Pageaux Claire Vanlemmens Fran?oise Roudot-Thoraval Anne-Laure Vincens-Rolland Christophe Hézode Philippe Gaulard Jean-Philippe Miguet Dominique Larrey Daniel Dhumeaux Daniel Cherqui 2002Transplantation2002,,8:1
9Effectiveness of Telaprevir or Boceprevir in Treatment-Experienced Patients With HCV Genotype 1 Infection and Cirrhosis显示文摘Christophe Hezode Helene Fontaine Celine Dorival Fabien Zoulim Dominique Larrey Valerie Canva Victor De Ledinghen Thierry Poynard Didier Samuel Marc Bourliere Laurent Alric Jean–Jacques Raabe Jean–Pierre Zarski Patrick Marcellin Ghassan Riachi Pierre–Henr 2014Gastroenterology2014,,:1
10Crizotinib-induced acute hepatitis: First case with relapse after reintroduction with reduced dose显示文摘Marie-Pierre Ripault Véronique Pinzani Véronique Fayolle Georges-Philippe Pageaux Dominique Larrey 2012Clinics and Research in Hepatology and Gastroenterology2012,,:1
11Herbal medicine hepatotoxicity: A new step with development of specific biomarkers显示文摘Dominique Larrey Stéphanie Faure 2011Journal of Hepatology2011,,4:1
12SCH 503034, a Novel Hepatitis C Virus Protease Inhibitor, Plus Pegylated Interferon α-2b for Genotype 1 Nonresponders显示文摘Christoph Sarrazin Regine Rouzier Frank Wagner Nicole Forestier Dominique Larrey Samir K. Gupta Musaddeq Hussain Amrik Shah David Cutler Jenny Zhang Stefan Zeuzem 2007Gastroenterology2007,,4:1
13Efficacy of the Protease Inhibitor BI 201335, Polymerase Inhibitor BI 207127, and Ribavirin in Patients With Chronic HCV Infection显示文摘Stefan Zeuzem Tarik Asselah Peter Angus Jean–Pierre Zarski Dominique Larrey Beat Müllhaupt Ed Gane Marcus Schuchmann Ansgar Lohse Stanislas Pol Jean–Pierre Bronowicki Stuart Roberts Keikawus Arasteh Fabien Zoulim Markus Heim Jerry O. Stern George Kukolj G 2011Gastroenterology2011,,6:1
14Liver toxicity of TNFα antagonists显示文摘Larrey Dominique 2008Joint Bone Spine2008,,6:1
15Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication显示文摘Stéphanie Faure Astrid Herrero Boris Jung Yohan Duny Jean-Pierre Daures Thibaut Mura Eric Assenat Micha?l Bismuth Hassan Bouyabrine Hélène Donnadieu-Rigole Francis Navarro Samir Jaber Dominique Larrey Georges-Philippe Pageaux 2012Journal of Hepatology2012,,2:1
16A randomized controlled trial of high-dose ursodesoxycholic acid for nonalcoholic steatohepatitis显示文摘Vlad Ratziu Victor de Ledinghen Fréderic Oberti Philippe Mathurin Claire Wartelle-Bladou Christophe Renou Philippe Sogni Marianne Maynard Dominique Larrey Lawrence Serfaty Dominique Bonnefont-Rousselot Jean-Philippe Bastard Marc Rivière Jean Spénard 2011Journal of Hepatology2011,,5:1
17Excessive alcohol consumption after liver transplantation impacts on long-term survival, whatever the primary indication显示文摘Stéphanie Faure Astrid Herrero Boris Jung Yohan Duny Jean-Pierre Daures Thibaut Mura Eric Assenat Micha?l Bismuth Hassan Bouyabrine Hélène Donnadieu-Rigole Francis Navarro Samir Jaber Dominique Larrey Georges-Philippe Pageaux 2012Journal of Hepatology2012,,2:1
18The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus显示文摘Sonia Molina Valérie Castet Chantal Fournier-Wirth Lydiane Pichard-Garcia Rachel Avner Dror Harats Joseph Roitelman Ronald Barbaras Pierre Graber Paola Ghersa Moshe Smolarsky Ada Funaro Fabio Malavasi Dominique Larrey Joliette Coste Jean-Michel Fabre Anto 2006Journal of Hepatology2006,,3:1
19Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) – NCT01514890显示文摘Christophe Hézode Hélène Fontaine Céline Dorival Dominique Larrey Fabien Zoulim Valérie Canva Victor de Ledinghen Thierry Poynard Didier Samuel Marc Bourlière Jean-Pierre Zarski Jean-Jacques Raabe Laurent Alric Patrick Marcellin Ghassan Riachi Pierre-Henr 2013Journal of Hepatology2013,,:1
20Genetic predisposition to drug-induced hepatotoxicity显示文摘Dominique Larrey Georges Philippe Pageaux 1997Journal of Hepatology1997,,:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费